Pharma & Biotech
Total enrollment in its Phase 2B study recently surpassed 70% and patient recruitment has accelerated
08.41 Thu 28 Nov 2019
Antibe Therapeutics is ready for a big push as it progresses pain management drug through clinical trials
BevCanna aims to capitalize on the emerging global cannabis beverage market
ImmunoPrecise Antibodies expecting significant revenue growth in 2019
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.